Successful treatment of plantar warts using topical Zijinding, a traditional Chinese medicine preparation: A case series.
J Cosmet Dermatol
; 19(4): 946-950, 2020 Apr.
Article
de En
| MEDLINE
| ID: mdl-31479180
ABSTRACT
INTRODUCTION:
Plantar warts are associated with high transmissibility and morbidity. Among the available therapeutic options, none is uniformly effective or virucidal. Salicylic acid is the first-line therapy but approximately one-third of lesions could not resolve and become recalcitrant despite repeated treatment. Cryotherapy is widely accessible with low cost but may be complicated by pain, blister formation, hemorrhage, infection, excessive granulation tissue formation, and hyper-/hypo-pigmentation. Hence, alternative treatment modalities are essential.METHODS:
Three patients with debilitating plantar warts refractory or intolerant to cryotherapy were treated with a course of Zijinding (a traditional Chinese medicine preparation) paste prepared with white vinegar.RESULTS:
All three patients showed excellent clinical response with Zijinding application with evolution of lesions to scabs and subsequently healthy skin within 1.5 to 5 months of treatment. Treatment was well tolerated and had no significant side effects with excellent compliance recorded for all three patients. There was no relapse for at least 10 months after stopping the treatment.CONCLUSION:
Topical Zijinding could be a promising alternative modality for the treatment of plantar warts. Further clinical trials on the comparison of Zijinding and other treatment modalities of plantar warts are warranted. Further studies are required to investigate the mechanism of action of Zijinding and to isolate the active ingredient.Mots clés
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Verrues
/
Médicaments issus de plantes chinoises
/
Prévention secondaire
/
Dermatoses du pied
Limites:
Adult
/
Female
/
Humans
/
Male
Langue:
En
Journal:
J Cosmet Dermatol
Sujet du journal:
DERMATOLOGIA
Année:
2020
Type de document:
Article
Pays d'affiliation:
Chine